Search Results - Horak, Peter
- Showing 1 - 20 results of 33
- Go to Next Page
-
1
-
2
A Cipher Based on Prefix Codes by Grošek, Otokar, Hromada, Viliam, Horák, Peter
Published 2021Text -
3
-
4
-
5
-
6
-
7
Circulating Endothelial Progenitor Cells in Castration Resistant Prostate Cancer: A Randomized, Controlled, Biomarker Study by Fuereder, Thorsten, Wacheck, Volker, Strommer, Sabine, Horak, Peter, Gerschpacher, Marion, Lamm, Wolfgang, Kivaranovic, Danijel, Krainer, Michael
Published 2014Text -
8
MALAT1 Fusions and Basal Cells Contribute to Primary Resistance against Androgen Receptor Inhibition in TRAMP Mice by Marhold, Maximilian, Udovica, Simon, Topakian, Thais, Horak, Peter, Horvat, Reinhard, Tomasich, Erwin, Heller, Gerwin, Krainer, Michael
Published 2022Text -
9
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast by Marhold, Maximilian, Tomasich, Erwin, Schwarz, Michael, Udovica, Simon, Heinzel, Andreas, Mayer, Paul, Horak, Peter, Perco, Paul, Krainer, Michael
Published 2018Text -
10
PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome by Bekos, Christine, Pils, Dietmar, Dekan, Sabine, Hofstetter, Gerda, Horak, Peter, Reinthaller, Alexander, Polterauer, Stephan, Schwameis, Richard, Aust, Stefanie
Published 2021Text -
11
Patient expectations are better for immunotherapy than traditional chemotherapy for cancer by Ihrig, Andreas, Richter, Jenniffer, Grüllich, Carsten, Apostolidis, Leonidas, Horak, Peter, Villalobos, Matthias, Grapp, Miriam, Friederich, Hans-Christoph, Maatouk, Imad
Published 2020Text -
12
-
13
-
14
The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer by Aust, Stefanie, Horak, Peter, Pils, Dietmar, Pils, Sophie, Grimm, Christoph, Horvat, Reinhard, Tong, Dan, Schmid, Bernd, Speiser, Paul, Reinthaller, Alexander, Polterauer, Stephan
Published 2013Text -
15
Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations by Simon, Malte, Mughal, Sadaf S., Horak, Peter, Uhrig, Sebastian, Buchloh, Jonas, Aybey, Bogac, Stenzinger, Albrecht, Glimm, Hanno, Fröhling, Stefan, Brors, Benedikt, Imbusch, Charles D.
Published 2021Text -
16
Correction to: Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations by Simon, Malte, Mughal, Sadaf S., Horak, Peter, Uhrig, Sebastian, Buchloh, Jonas, Aybey, Bogac, Stenzinger, Albrecht, Glimm, Hanno, Fröhling, Stefan, Brors, Benedikt, Imbusch, Charles D.
Published 2022Text -
17
TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo by Horak, Peter, Tomasich, Erwin, Vaňhara, Petr, Kratochvílová, Kateřina, Anees, Mariam, Marhold, Maximilian, Lemberger, Christof E., Gerschpacher, Marion, Horvat, Reinhard, Sibilia, Maria, Pils, Dietmar, Krainer, Michael
Published 2014Text -
18
Community-driven development of a modified progression-free survival ratio for precision oncology by Mock, Andreas, Heilig, Christoph E, Kreutzfeldt, Simon, Huebschmann, Daniel, Heining, Christoph, Schröck, Evelin, Brors, Benedikt, Stenzinger, Albrecht, Jäger, Dirk, Schlenk, Richard, Glimm, Hanno, Fröhling, Stefan, Horak, Peter
Published 2019Text -
19
A nanoporous gold membrane for sensing applications by Oo, Swe Zin, Silva, Gloria, Carpignano, Francesca, Noual, Adnane, Pechstedt, Katrin, Mateos, Luis, Grant-Jacob, James A., Brocklesby, Bill, Horak, Peter, Charlton, Martin, Boden, Stuart A., Melvin, Tracy
Published 2016Text -
20
Ruxolitinib is effective in the treatment of a patient with refractory T‐ALL by Jaramillo, Sonia, Hennemann, Hannah, Horak, Peter, Teleanu, Veronica, Heilig, Christoph E., Hutter, Barbara, Stenzinger, Albrecht, Glimm, Hanno, Goeppert, Benjamin, Müller‐Tidow, Carsten, Fröhling, Stefan, Schönland, Stefan, Schlenk, Richard F.
Published 2020Text